Streetbeat News

Analyst Ratings

ELEV

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on Elevation Oncology (NASDAQ:ELEV) and raises the price target from $1.5 to $6.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:56 pm

IOVA

HC Wainwright & Co. analyst Joseph Pantginis maintains a Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA) and raises the price target from $28 to $32.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:52 pm

GLSI

HC Wainwright & Co. analyst Yi Chen maintains a Buy rating on Greenwich LifeSciences (NASDAQ:GLSI) but lowers the price target from $38 to $36.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:47 pm

GAU

HC Wainwright & Co. analyst Heiko Ihle has reiterated a Buy rating on Galiano Gold (AMEX:GAU) with a maintained price target of $2.2.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:45 pm

NRIX

HC Wainwright & Co. analyst Robert Burns maintains a Buy rating on Nurix Therapeutics (NASDAQ:NRIX) but lowers the price target from $35 to $19.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:35 pm

YMAB

HC Wainwright & Co. analyst Robert Burns maintains a Buy rating on Y-mAbs Therapeutics (NASDAQ:YMAB) and raises the price target from $11 to $21.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:33 pm

BKNG

Seaport Global analyst Aaron Kessler initiates coverage on Booking Holdings (NASDAQ:BKNG) with a Buy rating and a price target of $4380.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:26 pm

ADCT

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on ADC Therapeutics (NYSE:ADCT) and increased the price target from $3 to $9. This adjustment reflects a positive outlook on the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:23 pm

GMAB

HC Wainwright & Co. analyst Raghuram Selvaraju has reiterated a Buy rating on Genmab (NASDAQ:GMAB) and maintained a $50 price target.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 12:21 pm